37th Annual Advances in Heart Disease

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

37th Annual Advances in Heart Disease

Day 1
Day 2
Day 3

Playback speed

10 seconds

Lipoprotein(a) and CVD: Do Elevated Lp(a) Levels Contribute to CVD Risk? What Are the Effects of Statins, PCSK9-i, LDL Apheresis and ASOs Therapies?

By 37th Annual Advances in Heart Disease FEATURING Binh An Phan, Peter Ganz

1,822 views

January 29, 2021

Comments 7

Day 1

Results of the COMPASS and VOYAGER PAD Trials: Is Rivaroxaban in Com…

37th Annual Advances in Heart Disease

M. Creager

842 views

Managing Cannabis Use in Patients with Cardiovascular Disease

37th Annual Advances in Heart Disease

N. Benowitz, B. An Phan

448 views

Updates in Preoperative Evaluation in Patients Undergoing Non-cardia…

37th Annual Advances in Heart Disease

R. Eshima Mckay

367 views

Contemporary Approach for Managing PAD: What Are the Guideline Recom…

37th Annual Advances in Heart Disease

M. Creager, B. An Phan

258 views

Evaluation of Cryptogenic Strokes: How to Diagnose Them? Should You …

37th Annual Advances in Heart Disease

C. Hemphill, B. An Phan

543 views

Cardiac Rehabilitation: How Beneficial Is It? Can Patients Have CR a…

37th Annual Advances in Heart Disease

A. Beatty

26 views

Hypertrophic Cardiomyopathy: What Is the Role of Genetic Testing? Wh…

37th Annual Advances in Heart Disease

P. Ganz, T. Abraham

32 views

Lipoprotein(a) and CVD: Do Elevated Lp(a) Levels Contribute to CVD R…

37th Annual Advances in Heart Disease

B. An Phan, P. Ganz

1.8K views

Native Valve Endocarditis: How to Use the Duke Criteria and Echocard…

37th Annual Advances in Heart Disease

P. Ganz, H. Chambers

885 views

Myocardial Viability Testing and Coronary Revascularization in Ische…

37th Annual Advances in Heart Disease

J. MacGregor, P. Ganz

1.9K views

42:59

37th Annual Advances in Heart Disease

Updates in HFpEF Diagnosis and Treatment: Can the Identification of …

Feat. S. Solomon

04:19

37th Annual Advances in Heart Disease

What Are the Main Risk Factors that Need to Be Taken Into Account to…

Feat. S. Solomon, P. Ganz

Update on Hypertrophic Cardiomyopathy: How to Use Imaging for Diagno…

37th Annual Advances in Heart Disease

T. Abraham

955 views